Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varying doses of intravenous tranexamic acid for blood loss reduction after term vaginal delivery
PACTR202306670143734Not yet recruiting
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms). Primary endpoint: mean blood loss. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202306670143734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306670143734.